Gene

Sarepta Shares Tumble Following FDA’s Cautious Take on Elevidys Gene Therapy: What Investors Need to Know

July 19, 2025

Sarepta stock falls on FDA gene therapy Elevidys comment

Sarepta Therapeutics Faces a Crucial Crossroad: What Investors Must Know Now Sarepta Therapeutics (NASDAQ: SRPT) has found itself at the epicenter of a high-stakes drama in the biotech world, sending shockwaves through its stock and … Read more

Categories Business News Tags cautious, Elevidys, FDAs, Gene, investors, Sarepta, Shares, Therapy, Tumble

Gene Munster’s Top Tech Picks for H2 2025: What Investors Should Watch for in Deepwater’s Bold Forecast

July 5, 2025

Deepwater’s Gene Munster likes these tech plays in the second half of 2025

Tech Stocks and AI: The Hidden Goldmine Investors Can’t Afford to Ignore in 2025 The S&P 500’s remarkable rebound in the first half of 2025—climbing nearly 11% from April lows—has been powered largely by the … Read more

Categories Investing Tags Bold, Deepwaters, Forecast, Gene, investors, Munsters, Picks, Tech, Top, watch